NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Beihai Biotech

Beihai Biotech

Private
ZhuhaiHealthcare & Life Scienceshttps://bayhibiotech.com

Last Round

Series C

Extension

Dec 12, 2023

Total Funding Raised

$42.99M

Company Overview

Beihai Biotech is a biopharmaceutical company that develops innovative oncology drugs to address unmet clinical needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

oncology drug developmentbiopharmaceuticaldrug formulationalbumin-bound drugchemotherapydrug licensingclinical-stage biotechdrug delivery systembiotechpharma licensingcancer therapeuticsdrug pipelineR&D-focused pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beihai Biotech Comparables

Compare Beihai Biotech with similar companies based on industry and business-model similarity.

Beihai Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Conjupro Biotherapeutics, Inc.
86%
Sichuan Kelun Pharmaceutical Co Ltd
81%
CSPC Pharmaceutical Group Limited
80%

Beihai Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionDec 12, 2023
Series BOct 31, 2022
Series AJan 6, 2022
Series AJul 1, 2021
AngelJan 1, 2017

Beihai Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 12, 2023

    GAINS Investment Corporation participated in the round.

  • Oct 31, 2022

    $27.39M round led by Yikai Venture Capital.

Beihai Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beihai Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beihai Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersZhuhai
Employee Range-
Year Founded2013
Last FundingDec 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.